Researchers at the Mayo Clinic in Florida have discovered that an enzyme called PRSS3, or mesotrypsin, may help drive aggressive prostate cancer. Although they don't believe it is the only factor, they suggest it offers a new target for treatment, and have themselves developed a prototype...